Shim, JoannaDean, Linda EKarabayas , MairaJones, Gareth TMacfarlane, Gary JBasu, Neil2020-05-122020-05-122020-11-01Shim, J, Dean, L E, Karabayas , M, Jones, G T, Macfarlane, G J & Basu, N 2020, 'Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue : Results from the BSRBR-AS registry and meta-analysis', Rheumatology, vol. 59, no. 11, keaa132, pp. 3408-3414. https://doi.org/10.1093/rheumatology/keaa132, https://doi.org/10.1093/rheumatology/keaa1321462-0324ORCID: /0000-0003-2322-3314/work/73932826ORCID: /0000-0003-0016-7591/work/83703932PubMedCentral: PMC7590410ORCID: /0000-0002-4206-477X/work/119414334https://hdl.handle.net/2164/14306We are grateful to the staff of the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis register and to the recruiting staff at the clinical centres, details of which are available at: https://www.abdn.ac.uk/iahs/research/epidemiology/spondyloarthritis.php#panel1011. Funding: This work was supported by the British Society for Rheumatology (BSR) who have funded the BSRBR-AS. The BSR received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments but have no input in to the topics for analysis in the register nor the work involved in undertaking analysis. Analysis of data was supported by the Versus Arthritis/Medical Research Council Centre for Musculoskeletal Health and Work [grant number 20665].7362167engfatigueAnti-Tumour Necrosis FactorAxial Spondylarthritissleepregistrymeta-analysisR MedicinePharmacology (medical)RheumatologyMedical Research Council (MRC)Centre for Musculoskeletal Health and Workgrant number 20665Supplementary DataRJournal article10.1093/rheumatology/keaa132http://www.scopus.com/inward/record.url?scp=85094932438&partnerID=8YFLogxK5911